pyrazines has been researched along with bms 754807 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fogarty, FM; Kennedy, RD; Lyons, A; McCabe, N; O'Connor, R; O'Flanagan, CH; O'Shea, S | 1 |
Axelrod, MJ; Bekiranov, S; David, AP; Donaldson, L; Dougherty, MI; Frierson, HF; Gioeli, DG; Hubbard, MA; Jameson, MJ; Khalil, AA; Lehman, CE; McGarey, PO; Mendez, RE; Petricoin, EF; Schoeff, SS; Stelow, EB; Taniguchi, LE; Wulfkuhle, JD | 1 |
2 other study(ies) available for pyrazines and bms 754807
Article | Year |
---|---|
IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin.
Topics: Ataxia Telangiectasia Mutated Proteins; Biomarkers, Tumor; Breast Neoplasms; Cell Survival; Cisplatin; DNA Damage; Histones; Humans; Imidazoles; Inhibitory Concentration 50; MCF-7 Cells; Oncogenes; Phosphorylation; Pyrazines; Pyrazoles; Receptor, IGF Type 1; Receptors, Somatomedin; Recombinant Proteins; RNA, Small Interfering; Triazines | 2016 |
Antitumor effect of insulin-like growth factor-1 receptor inhibition in head and neck squamous cell carcinoma.
Topics: Head and Neck Neoplasms; Humans; Imidazoles; Insulin-Like Growth Factor I; Mouth Neoplasms; Neoplasm Staging; Pyrazines; Pyrazoles; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Triazines; Tumor Cells, Cultured | 2020 |